vTv Therapeutics Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: vTv Therapeutics Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: vTv Therapeutics Inc - Ordinary Shares - Class A
Rating: 1.46466675
Author: Trendlyne DVM scores

about

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its p...

20.06 1.04 (5.47%)

25.65% Fall from 52W High

6,154

XNAS Volume

XNAS 11 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

1.7 / 100

Technically Neutral

56.9 / 100

1Yr Price target upside is 77%

2 analysts

vTv Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

vTv Therapeutics Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its p...

25.65% Fall from 52W High

SWOT Analysis

vTv Therapeutics Inc Live Price Chart